Adverse Event Clinical Research
1.0.1 - STU1

Adverse Event Clinical Research, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-ig/ and changes regularly. See the Directory of published versions

## MedicationRequest: medication-request-example-kadcyla1

Page standards status: Informative

Generated Narrative: MedicationRequest

Resource MedicationRequest "medication-request-example-kadcyla1"

status: active

intent: order

### Medications

- | Concept
* | KADCYLA (RxNorm#1371046)

subject: Patient/patient-example-kaitlyn-b1 " HAMMER"

authoredOn: 2020-03-15

requester: Practitioner/practitioner-owen-oncologist " ONCOLOGIST"

> dosageInstruction

> text: Kadcyla IV at 3.6mg

> timing: Starting 2020-04-03, Once

> route: Intravenous route (qualifier value) (SNOMED CT#47625008)

> > doseAndRate

> maxDosePerAdministration: 1